• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-26a 通过抑制 EZH2 抑制鼻咽癌的细胞生长和肿瘤发生。

MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2.

机构信息

Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.

出版信息

Cancer Res. 2011 Jan 1;71(1):225-33. doi: 10.1158/0008-5472.CAN-10-1850.

DOI:10.1158/0008-5472.CAN-10-1850
PMID:21199804
Abstract

Several microRNAs (miRNA) have been implicated in nasopharyngeal carcinoma (NPC), a highly invasive and metastatic cancer that is widely prevalent in southern China. In this study, we report that microRNA miR-26a is commonly downregulated in NPC specimens and NPC cell lines with important functional consequences. Ectopic expression of miR-26a dramatically suppressed cell proliferation and colony formation by inducing G(1)-phase cell-cycle arrest. We found that miR-26a strongly reduced the expression of EZH2 oncogene in NPC cells. Similar to the restoring miR-26 expression, EZH2 downregulation inhibited cell growth and cell-cycle progression, whereas EZH2 overexpression rescued the suppressive effect of miR-26a. Mechanistic investigations revealed that miR-26a suppressed the expression of c-myc, the cyclin D3 and E2, and the cyclin-dependent kinase CDK4 and CDK6 while enhancing the expression of CDK inhibitors p14(ARF) and p21(CIP1) in an EZH2-dependent manner. Interestingly, cyclin D2 was regulated by miR-26a but not by EZH2, revealing cyclin D2 as another direct yet mechanistically distinct target of miR-26a. In clinical specimens, EZH2 was widely overexpressed and its mRNA levels were inversely correlated with miR-26a expression. Taken together, our results indicate that miR-26a functions as a growth-suppressive miRNA in NPC, and that its suppressive effects are mediated chiefly by repressing EZH2 expression.

摘要

几种 microRNAs(miRNA)已被牵连到鼻咽癌(NPC)中,这是一种在华南地区广泛流行的高度侵袭性和转移性癌症。在这项研究中,我们报告了 microRNA miR-26a 在 NPC 标本和 NPC 细胞系中普遍下调,并具有重要的功能后果。miR-26a 的异位表达通过诱导 G1 期细胞周期停滞,显著抑制了细胞增殖和集落形成。我们发现 miR-26a 在 NPC 细胞中强烈降低了 EZH2 癌基因的表达。类似于恢复 miR-26 的表达,EZH2 的下调抑制了细胞生长和细胞周期进程,而 EZH2 的过表达挽救了 miR-26a 的抑制作用。机制研究表明,miR-26a 以 EZH2 依赖的方式抑制了 c-myc、cyclin D3 和 E2、细胞周期蛋白依赖性激酶 CDK4 和 CDK6 的表达,同时增强了 CDK 抑制剂 p14(ARF)和 p21(CIP1)的表达。有趣的是,cyclin D2 受 miR-26a 调节但不受 EZH2 调节,表明 cyclin D2 是 miR-26a 的另一个直接但机制上不同的靶标。在临床标本中,EZH2 广泛过表达,其 mRNA 水平与 miR-26a 的表达呈负相关。总之,我们的结果表明,miR-26a 在 NPC 中作为生长抑制性 miRNA 发挥作用,其抑制作用主要通过抑制 EZH2 的表达来介导。

相似文献

1
MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2.miR-26a 通过抑制 EZH2 抑制鼻咽癌的细胞生长和肿瘤发生。
Cancer Res. 2011 Jan 1;71(1):225-33. doi: 10.1158/0008-5472.CAN-10-1850.
2
MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2.微小RNA-26a通过抑制zeste同源物2增强子来抑制人肝细胞癌中的上皮-间质转化。
J Hematol Oncol. 2016 Jan 6;9:1. doi: 10.1186/s13045-015-0229-y.
3
MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.微小 RNA-101 通过直接靶向增强子结合锌指蛋白 2 在非小细胞肺癌中发挥肿瘤抑制功能。
J Thorac Oncol. 2011 Apr;6(4):671-8. doi: 10.1097/JTO.0b013e318208eb35.
4
Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer.病理性降低的 miR-26a 通过靶向乳腺癌中的 MTDH 和 EZH2 拮抗细胞凋亡并促进癌发生。
Carcinogenesis. 2011 Jan;32(1):2-9. doi: 10.1093/carcin/bgq209. Epub 2010 Oct 15.
5
MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.微小 RNA-101 通过下调 EZH2 并增加细胞抑制性药物敏感性抑制人肝癌进展。
J Hepatol. 2014 Mar;60(3):590-8. doi: 10.1016/j.jhep.2013.10.028. Epub 2013 Nov 6.
6
miR-26a inhibits invasion and metastasis of nasopharyngeal cancer by targeting EZH2.微小RNA-26a通过靶向EZH2抑制鼻咽癌的侵袭和转移。
Oncol Lett. 2013 Apr;5(4):1223-1228. doi: 10.3892/ol.2013.1173. Epub 2013 Feb 4.
7
MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN.微小 RNA-144 通过抑制 PTEN 促进鼻咽癌中的细胞增殖、迁移和侵袭。
Carcinogenesis. 2013 Feb;34(2):454-63. doi: 10.1093/carcin/bgs346. Epub 2012 Nov 3.
8
miR-26a promoted by interferon-alpha inhibits hepatocellular carcinoma proliferation and migration by blocking EZH2.由α干扰素促进的miR-26a通过阻断EZH2抑制肝细胞癌的增殖和迁移。
Genet Test Mol Biomarkers. 2015 Jan;19(1):30-6. doi: 10.1089/gtmb.2014.0245.
9
miR-9 targets CXCR4 and functions as a potential tumor suppressor in nasopharyngeal carcinoma.miR-9 靶向 CXCR4,作为潜在的鼻咽癌肿瘤抑制因子发挥作用。
Carcinogenesis. 2014 Mar;35(3):554-63. doi: 10.1093/carcin/bgt354. Epub 2013 Oct 29.
10
Mutant p53 induces EZH2 expression and promotes epithelial-mesenchymal transition by disrupting p68-Drosha complex assembly and attenuating miR-26a processing.突变型p53通过破坏p68-Drosha复合体组装并减弱miR-26a加工过程来诱导EZH2表达并促进上皮-间质转化。
Oncotarget. 2015 Dec 29;6(42):44660-74. doi: 10.18632/oncotarget.6350.

引用本文的文献

1
Divergent Functions of Rap1A and Rap1B in Endothelial Biology and Disease.Rap1A和Rap1B在内皮生物学与疾病中的不同功能
Int J Mol Sci. 2025 Jun 4;26(11):5372. doi: 10.3390/ijms26115372.
2
BRD4 expression and its regulatory interaction with miR-26a-3p, DLG5-AS1, and JMJD1C-AS1 lncRNAs in gastric cancer progression.BRD4在胃癌进展中的表达及其与miR-26a-3p、DLG5-AS1和JMJD1C-AS1长链非编码RNA的调控相互作用。
Discov Oncol. 2024 Aug 16;15(1):356. doi: 10.1007/s12672-024-01230-7.
3
MiR26a reverses enzalutamide resistance in a bone-tumor targeted system with an enhanced effect on bone metastatic CRPC.
miR26a 在骨肿瘤靶向系统中逆转恩杂鲁胺耐药,对骨转移去势抵抗性前列腺癌具有增强作用。
J Nanobiotechnology. 2024 Apr 2;22(1):145. doi: 10.1186/s12951-024-02438-z.
4
Hypoxia macrophage-derived exosomal miR-26b-5p targeting PTEN promotes the development of keloids.缺氧巨噬细胞来源的外泌体miR-26b-5p靶向PTEN促进瘢痕疙瘩的发展。
Burns Trauma. 2024 Feb 29;12:tkad036. doi: 10.1093/burnst/tkad036. eCollection 2024.
5
MicroRNA-Mediated Regulation of Histone-Modifying Enzymes in Cancer: Mechanisms and Therapeutic Implications.miRNA 介导的癌症中组蛋白修饰酶的调节:机制和治疗意义。
Biomolecules. 2023 Oct 28;13(11):1590. doi: 10.3390/biom13111590.
6
Regulation of the Cell Cycle by ncRNAs Affects the Efficiency of CDK4/6 Inhibition.ncRNAs 通过调控细胞周期影响 CDK4/6 抑制的效率。
Int J Mol Sci. 2023 May 18;24(10):8939. doi: 10.3390/ijms24108939.
7
Pharmacological impact of microRNAs in head and neck squamous cell carcinoma: Prevailing insights on molecular pathways, diagnosis, and nanomedicine treatment.微小RNA在头颈部鳞状细胞癌中的药理作用:关于分子途径、诊断及纳米医学治疗的当前见解
Front Pharmacol. 2023 May 3;14:1174330. doi: 10.3389/fphar.2023.1174330. eCollection 2023.
8
circEZH2 is a dual suppressor of miR363/miR708 to promote EZH2 expression and prostate cancer progression.circEZH2 是 miR363/miR708 的双重抑制剂,可促进 EZH2 表达和前列腺癌进展。
Cancer Sci. 2023 Apr;114(4):1378-1395. doi: 10.1111/cas.15694. Epub 2022 Dec 28.
9
PAIP1 is a novel oncogene in human hepatocellular carcinoma.PAIP1是人类肝细胞癌中的一种新型癌基因。
Discov Oncol. 2022 Nov 27;13(1):132. doi: 10.1007/s12672-022-00530-0.
10
lncRNA Malat1 and miR-26 cooperate in the regulation of neuronal progenitor cell proliferation and differentiation.长链非编码RNA Malat1与miR-26协同调控神经祖细胞的增殖与分化。
RNA. 2022 Oct 27;29(1):69-81. doi: 10.1261/rna.079436.122.